Evidence map›Paper›PMID 40615579›Full record

ArticleEMBO reports2025

Identification of a fungal antibacterial endopeptidase that cleaves peptidoglycan.

Silke Machata, Ute Bertsche, Franziska Hoffmann, Zaher M Fattal, Franziska Kage, Michal Flak, Alexander N J Iliou, Falk Hillmann, Ferdinand von Eggeling, Hortense Slevogt and 2 more

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silke MachataMicrobial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.
Ute BertscheUniversity of Hohenheim, Core Facility - Module 1 Mass Spectrometry Unit, Stuttgart, Germany.ORCID 0000-0002-1897-5557
Franziska HoffmannDepartment of Otorhinolaryngology, Jena University Hospital, Jena, Germany.
Zaher M FattalMicrobial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.
Franziska KageMicrobial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.ORCID 0009-0003-3681-3433
Michal FlakMolecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.
Alexander N J IliouEvolution of Microbial Interactions, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.
Falk HillmannEvolution of Microbial Interactions, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.ORCID 0000-0002-5493-930X
Ferdinand von EggelingDepartment of Otorhinolaryngology, Jena University Hospital, Jena, Germany.ORCID 0000-0002-8062-6999
Hortense SlevogtDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, German Center for Lung Research (DZL), BREATH, Hannover, Germany.
Axel A BrakhageMolecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.ORCID 0000-0002-8814-4193
Ilse D JacobsenMicrobial Immunology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany. ilse.jacobsen@leibniz-hki.de.ORCID 0000-0002-6033-9984

Funding

Bundesministerium für Bildung und Forschung (BMBF) 13GW0096EDeutsche Forschungsgemeinschaft (DFG) 210879364,Project Z2
6 · The paper itself

Abstract

Aspergillus fumigatus is a saprophytic fungus dwelling in soil and on decaying plant material, but also an opportunistic pathogen in immunocompromised patients. In its environmental niche, A. fumigatus faces competition from other microorganisms including bacteria. Here, we describe the discovery of the first secreted antibacterial protein in A. fumigatus. We identify a secreted fungal endopeptidase, designated CwhA, that cleaves peptidoglycan of Gram-positive bacteria at specific residues within the peptidoglycan stem peptide. Cleavage leads to bacterial lysis and the release of peptidoglycan cleavage products. Expression of cwhA is induced by the presence of bacteria. Furthermore, CwhA is highly abundant in murine lungs during invasive pulmonary aspergillosis and peptidoglycan cleavage products generated by CwhA stimulate cytokine production of human immune cells in vitro. Although CwhA does not affect human cells directly, this novel player in fungal-bacterial interactions could affect A. fumigatus infections by inhibiting Gram-positive bacteria in its vicinity, and possibly modulate the immune system.

Indexed as

Anti-Bacterial AgentsAspergillus fumigatusEndopeptidasesFungal ProteinsPeptidoglycanAnimalsAspergillosisCytokinesGram-Positive BacteriaHumansMiceAnti-Bacterial AgentsCytokinesEndopeptidasesFungal ProteinsPeptidoglycanAspergillus fumigatusCell WallFungal–Bacterial InteractionsStaphylococcus aureus

Identifiers

PMID40615579
PMCPMC12332128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.